Article
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma
16 Jan 2025
Abstract excerpt
PURPOSE: Renal cell carcinoma (RCC) is a common malignancy, with patients frequently diagnosed at an advanced stage due to the absence of sufficiently sensitive detection technologies, significantly compromising patient survival and quality of life. Advances in cell-free DNA (cfDNA) methylation profiling using liquid biopsies offer a promising non-invasive diagnostic option, but robust biomarkers for early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
